Patients are becoming overinformed and chronic disease is increasing
Chabot, J.-M.
La Revue du Praticien 59(7): 977-978
2009
ISSN/ISBN: 0035-2640 PMID: 19839471 Document Number: 631945
Document emailed within 1 workday
Related Documents
Goicoechea, M.A. 2004: Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl (6): 142-160; 187-235Gottlieb, A.B.; Gordon, K.B.; Lebwohl, M.G.; Caro, I.; Walicke, P.A.; Li, N.; Leonardi, C.L. 2004: Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis Journal of Drugs in Dermatology: Jdd 3(6): 614-624
Barczyk, A.; Pierzchała, W.; Sozańska, E. 2001: Levels of CC-chemokine (MCP-1 alpha, MIP-1 beta) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Pneumonologia i Alergologia Polska 69(1-2): 40-49
Frassoni, F.; Martinelli, G.; Saglio, G.; Sessarego, M.; Podestà, M.; Piaggio, G.; Farabegoli, P.; Zaccaria, A.; Testoni, N.; Remiddi, C. 1995: bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase Bone Marrow Transplantation 16(4): 595-601
Kosmachev, A.A.; Guliev, A.B.; Sidorenko, B.A.; Liakishev, A.A. 1989: Increasing the threshold of skin sensitivity to pain in patients with a predominantly painless form of ischemic heart disease Kardiologiia 29(1): 56-59
Strel'nikova, V.A.; Mochalova, T.P. 1985: Possibilities of hemosorption for increasing the effectiveness of treatment of patients with renal tuberculosis with chronic renal insufficiency Problemy Tuberkuleza 9: 48-50
Gheorghiade, M.; Hall, V.B.; Jacobsen, G.; Alam, M.; Rosman, H.; Goldstein, S. 1995: Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors Circulation 92(7): 1801-1807
Salvagnone, E.; Morreale, S. 1973: Value of spirometric functional tests in patients with chronic bronchitis and chronic pulmonary heart disease Bollettino Della Societa Italiana di Cardiologia 18(3): 293-299
Tarhan, S.; Moffitt, E.A.; Sessler, A.D.; Douglas, W.W.; Taylor, W.F. 1973: Risk of anesthesia and surgery in patients with chronic bronchitis and chronic obstructive pulmonary disease Surgery 74(5): 720-726
Ruilope, L.M.; Aldigier, J.C.; Ponticelli, C.; Oddou-Stock, P.; Botteri, F.; Mann, J.F. 2000: Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease Journal of Hypertension 18(1): 89-95
Hayes, P.C.; Bouchier, I.A. 1989: Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease American Journal of Gastroenterology 84(7): 723-726
Zhelezniakova, N. 2013: Formation of immune distress syndrome in patients with combined course of chronic obstructive pulmonary disease and chronic pancreatitis Georgian Medical News 214: 19-23
Strutynskiĭ, A.V.; Bakaev, R.G.; Glazunov, A.B.; Banzeliuk, E.N.; Moshkova, N.K.; Reĭsner, A.A.; Shavurdina, S.V.; Vinogradova, D.V. 2010: The specific features of left cardiac cavity remodeling in patients with chronic obstructive pulmonary disease and chronic cor pulmonale Terapevticheskii Arkhiv 82(9): 45-49
Mule, A.; Sirohi, P.; Ram, N. 2018: Prevalence of Chronic Liver Disease Among the Patients of Celiac Disease and Effect of Gluten-Free Diet on Outcome of Liver Disease: a Prospective Study Journal of the Association of Physicians of India 66(3): 34-36
Cai, Q.; Mukku, V.K.; Ahmad, M. 2013: Coronary artery disease in patients with chronic kidney disease: a clinical update Current Cardiology Reviews 9(4): 331-339
Ishii, H.; Murohara, T. 2011: Interventional revascularization for cardiovascular disease in patients with chronic kidney disease Nihon Rinsho. Japanese Journal of Clinical Medicine 69(2): 339-342
Borycki, E. 2012: M-health: can chronic obstructive pulmonary disease patients use mobile phones and associated software to self-manage their disease? Studies in Health Technology and Informatics 172: 79-84
Shoĭkhet, I.N.; Klester, E.B. 2010: Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease Terapevticheskii Arkhiv 82(2): 25-28
Kozák, P. 1982: Increasing the sensitivity of systolic time intervals in coronary heart disease patients by means of stimulated tachycardia and pharmacological heart loads (isoproterenol, nitroglycerine, propranolol) Acta Universitatis Carolinae. Medica 28(5-6): 369-382
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305